Cytotoxic effectors in human peripheral blood mononuclear cells induced by a mannoprotein complex of Candida albicans: A comparison with interleukin 2-activated killer cells

This publication has 65 references indexed in Scilit:

• Immunotherapy of cancer using interleukin 2: current status and future prospects
  Immunology Today, 1988
• Functional differentiation of human lymphokine-activated killing (LAK) is distinct from expansion and involves dissimilar interleukin 2 receptors
  Cellular Immunology, 1988
• Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleen
  Immunology Today, 1987
• Natural killer activity: the definition of a function rather than a cell type
  Immunology Today, 1987
• Characterization of human leukocyte differentiation antigens
  Immunology Today, 1987
• Lysis of fresh solid tumor targets in the presence of Con A is mediated primarily by Leu 7+ peripheral blood T lymphocytes: Blocking by the anti-CD3 monoclonal antibody and comparison with recombinant interleukin 2-induced lysis by natural killer cells
  Cellular Immunology, 1987
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
  New England Journal of Medicine, 1987
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985
• Murine monoclonal antibodies as probes for the phenotypical, functional, and molecular analysis of a discrete peripheral blood lymphocyte population exerting natural killer activity in vitro
  Human Immunology, 1985